Valo Therapeutics (Valo TX) has partnered with ImmunoScape to identify immunogenic peptides for pan-coronavirus vaccine development. The detected conserved peptide sequences will be applied to adenoviruses to address efficacy problems with existing vaccines against novel Covid-19 variants. Valo Therapeutics’ PeptiVAX platform offers a flexible and quick approach to address variants by coating the adenovirus with the associated clinical-grade target […]

Affinity Empowering, Inc., a leading provider of the most sophisticated and secure occupational and behavioral health services, announced the launch of Affinity COVID Clinic, a full service COVID strategy and support station that can be placed in retail sites to bring COVID-19 testingand related services to local communities. The launch of the Affinity COVID Clinic […]

A phase 2 clinical trial (NCT04436029) has been initiated to evaluate Descartes-11, an mRNA CAR T-cell therapy, as a consolidative therapy in patients with newly diagnosed, high-risk multiple myeloma who have residual disease after induction therapy.1 To date, Descartes-11 is the first RNA-engineered cellular therapy to enter clinical development for the frontline treatment of cancer, […]